416 related articles for article (PubMed ID: 34006241)
21. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
22. Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study.
Xu B; Zhang F; Wu R; Peng Y; Mao Z; Tong S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15657-15669. PubMed ID: 37656242
[TBL] [Abstract][Full Text] [Related]
23. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
24. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
[TBL] [Abstract][Full Text] [Related]
25. Nomogram for predicting survival after lymphatic metastasis in esophageal cancer: A SEER analysis.
Sun S; Yang W; Yang Y; Fan M; Wang F; He L; Han B; Chen C
Medicine (Baltimore); 2023 Aug; 102(31):e34189. PubMed ID: 37543759
[TBL] [Abstract][Full Text] [Related]
26. Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors.
He Y; Zhao F; Han Q; Zhou Y; Zhao S
BMC Cancer; 2021 Feb; 21(1):141. PubMed ID: 33557782
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
Jiang AG; Cai X
BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
[TBL] [Abstract][Full Text] [Related]
28. Predicting the Survival Probability of Neuroendocrine Tumor Populations: Developing and Evaluating a New Predictive Nomogram.
Chen JX; Lin Y; Meng YL; Zhao AX; Huang XJ; Liang R; Li YQ; Liu ZH
Biomed Res Int; 2021; 2021():9126351. PubMed ID: 33575356
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for preoperative estimation of histologic grade in gastrointestinal neuroendocrine tumors.
Wu ZQ; Li Y; Sun NN; Xu Q; Zhou J; Su KK; Goyal H; Xu HG
Front Endocrinol (Lausanne); 2022; 13():991773. PubMed ID: 36353229
[TBL] [Abstract][Full Text] [Related]
30. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
[TBL] [Abstract][Full Text] [Related]
31. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
[TBL] [Abstract][Full Text] [Related]
32. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
Wang J; Chen L; Nie Y; Wu W; Yao Y
Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
[TBL] [Abstract][Full Text] [Related]
33. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
Front Public Health; 2022; 10():884349. PubMed ID: 35712294
[TBL] [Abstract][Full Text] [Related]
34. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms.
Sun S; Wang W; He C
Med Sci Monit; 2020 Jun; 26():e922613. PubMed ID: 32564052
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic nomograms for laryngeal carcinoma patients with lung metastasis: a SEER-based study.
Qu W; Qin Z; Cui L; Yuan S; Yao N; Ma J; Lu J; Wang J; Wang M; Yao Y
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3071-3082. PubMed ID: 38584217
[TBL] [Abstract][Full Text] [Related]
37. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
38. A Predictive Nomogram for Small Intestine Neuroendocrine Tumors.
Kelly S; Aalberg J; Kim MK; Divino CM
Pancreas; 2020 Apr; 49(4):524-528. PubMed ID: 32282765
[TBL] [Abstract][Full Text] [Related]
39. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
[TBL] [Abstract][Full Text] [Related]
40. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
